NFE2L2 and Familial prostate cancer: By contrast, knockdown of NRF2 in Casik cervical cancer cells, A549 non-small-cell lung cancer cells, and prostate cancer cells increased sensitivity to chemotherapeutic drugs and radiation [25,31–32].